» Articles » PMID: 39683414

Phytochemical, Cytoprotective Profiling, and Anti-Inflammatory Potential of in Rheumatoid Arthritis: An Experimental and Simulation Study

Overview
Journal Nutrients
Date 2024 Dec 17
PMID 39683414
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by severe pain, inflammation, and joint deformity. Currently, it affects 1% of the population, with a projection to exceed 23 million cases by 2030. Despite significant advancements, non-steroidal anti-inflammatory drugs (NSAIDs), the first line of treatment, are associated with a range of adverse effects. Consequently, plant-based derivatives are being utilized as an effective alternative. This study evaluates the anti-inflammatory and safety profile of hydroethanolic extract (CLHE) in comparison to NSAIDs, with a focus on COX-2 and TNFα inhibition.

Methods: CLHE potential was evaluated by phytochemical screening and in vitro bioactivity assays. Toxicity profile was conducted in Human Colon Epithelial Cells (HCEC) and Balb/c mice. Anti-inflammatory potential was explored in a collagen-induced arthritic (CIA) mice model. Bioactive compounds were identified computationally from GCMS data and subjected to docking and simulation studies against COX2 and TNFα.

Results: CLHE demonstrated significant antioxidant (IC-50 = 6.78 µg/mL) and anti-inflammatory (IC-50 = 97.39 µg/mL) activity. It maintained 50% cell viability at 78.5 μg/µL in HCEC cells and exhibited no toxicity at a dose of 5000 mg/kg in mice. In the CIA model, CLHE significantly reduced paw swelling, arthritic scoring, C-reactive protein levels, and spleen indices, outperforming ibuprofen. Expression analysis confirmed the downregulation of COX-2, TNFα, and MMP-9. Histopathological analysis indicated the superior efficacy of CLHE compared to ibuprofen in reducing inflammation, synovial hyperplasia, and bone erosion. Computational studies identified compound-15 (CL15), (4-(4,7-dimethoxy-1,3-benzodioxol-5-yl)-2-oxo pyrrolidine-3-carboxylic acid), a non-toxic compound with strong binding affinities to COX-2 (-12.9 KJ/mol), and TNF-α (-5.8 KJ/mol).

Conclusions: The findings suggest the potential of as a safer, anti-inflammatory, and multi-targeted alternative to NSAIDs for RA treatment.

References
1.
Luan J, Hu Z, Cheng J, Zhang R, Yang P, Guo H . Applicability and implementation of the collagen-induced arthritis mouse model, including protocols (Review). Exp Ther Med. 2021; 22(3):939. PMC: 8290431. DOI: 10.3892/etm.2021.10371. View

2.
Teixeira J, Silva A, Almeida M, Bessa-Goncalves M, Cunha C, Barbosa M . The Systemic Immune Response to Collagen-Induced Arthritis and the Impact of Bone Injury in Inflammatory Conditions. Int J Mol Sci. 2019; 20(21). PMC: 6862543. DOI: 10.3390/ijms20215436. View

3.
Jimenez R, Szalai A . Therapeutic Lowering of C-Reactive Protein. Front Immunol. 2021; 11:619564. PMC: 7901964. DOI: 10.3389/fimmu.2020.619564. View

4.
Oniga S, Pacureanu L, Stoica C, Palage M, Craciun A, Rusu L . COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles. Molecules. 2017; 22(9). PMC: 6151395. DOI: 10.3390/molecules22091507. View

5.
Nair V, Kumar R, Singh S, Gupta Y . Investigation into the anti-inflammatory and antigranuloma activity of Colchicum luteum Baker in experimental models. Inflammation. 2011; 35(3):881-8. DOI: 10.1007/s10753-011-9389-2. View